Articles

1. Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country

   • Najmeh Moradi
   • Leila Zarei
   • Kamran Bagheri Lankarani

   Original Research Article Open access 18 May 2024

   

2. Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension

   • Rod S. Taylor
   • Anthony Bentley
   • Roland E. Schmieder

   Correction Open access 08 May 2024

3. Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs

   • Micha J. Pilz
   • Simone Seyringer
   • the EORTC Quality of Life Group

   Original Research Article Open access 02 May 2024

   

4. Whither Decision-Analytic Modelling-Based Economic Evaluation for Health Care Decision Making?

   • Rachael Maree Hunter
   • Matthew Franklin

   Editorial Open access 25 April 2024

5. Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model

   • Emma McManus

   Original Research Article Open access 20 April 2024

   

6. Cost of Care for Non-communicable Diseases: Which Types of Healthcare Providers are the Most Economical in India’s Chhattisgarh State?

   • Samir Garg
   • Narayan Tripathi
   • Kirtti Kumar Bebarta

   Original Research Article Open access 17 April 2024

7. NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances

   • Dawn Lee
   • Darren Burns
   • Ed Wilson

   Editorial Open access 13 April 2024

8. Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older

   • Sydney George
   • Justin Carrico
   • Nikolaos Giannelos

   Original Research Article Open access 11 April 2024 Pages: 481 - 492

   

9. Behind the Scenes: A Qualitative Investigation of Interviewers' Performance in EQ-5D Valuation Studies

   • Carlotta Varriale
   • Giovanni Andrulli
   • Aureliano Paolo Finch

   Original Research Article Open access 09 April 2024 Pages: 389 - 401

   

10. Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus

    • Olga Pitsillidou
    • Panagiotis Petrou
    • M. J. Postma

    Original Research Article Open access 04 April 2024 Pages: 471 - 480

    

11. A Canadian Simulation Model for Major Depressive Disorder: Study Protocol

    • Shahzad Ghanbarian
    • Gavin W. K. Wong
    • Stirling Bryan

    Protocol Open access 26 March 2024 Pages: 493 - 505

    

12. Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany

    • Niklaus Meier
    • Hendrik Fuchs
    • Matthias Schwenkglenks

    Original Research Paper Open access 23 March 2024 Pages: 373 - 387

    

13. A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab

    • Sudewi Mukaromah Khoirunnisa
    • Fithria Dyah Ayu Suryanegara
    • Maarten Jacobus Postma

    Systematic Review Open access 15 March 2024

    

14. Identification and prioritisation of items for a draft participant-reported questionnaire to measure use of social care, informal care, aids and adaptations

    • Kirsty M. Garfield
    • Gail A. Thornton
    • Joanna C. Thorn

    Original Research Article Open access 07 March 2024 Pages: 431 - 443

    

15. A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales

    • Colin Burke
    • Catriona Crossan
    • Sally Bowditch

    Original Research Article Open access 05 March 2024

    

16. Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis

    • Christian Bührer
    • Thomas Paling
    • Marloes Bagijn

    Original Research Article Open access 04 March 2024 Pages: 445 - 457

    

17. Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease

    • Syed G. Mohiuddin
    • Mary E. Ward
    • Howard H. Z. Thom

    Systematic Review Open access 23 February 2024 Pages: 359 - 371

    

18. Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy

    • Elvio Emanuele Rossini
    • Carlotta Galeone
    • Claudio Jommi

    Correction Open access 12 February 2024 Pages: 345 - 345

19. Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

    • Tim Reason
    • Emma Benbow
    • Bill Malcolm

    Original Research Article Open access 10 February 2024 Pages: 205 - 220

    

20. Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

    • Tim Reason
    • William Rawlinson
    • Sven Klijn

    Original Research Article Open access 10 February 2024 Pages: 191 - 203

    

21. Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension

    • Rod S. Taylor
    • Anthony Bentley
    • Roland E. Schmieder

    Original Research Article Open access 30 January 2024

    

22. Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review

    • Malvina Hoxha
    • Visar Malaj
    • Bruno Zappacosta

    Systematic Review Open access 27 January 2024 Pages: 147 - 170

    

23. An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population

    • Joe W. E. Moss
    • Derick Todd
    • Prapa Kanagaratnam

    Original Research Article Open access 20 January 2024 Pages: 417 - 429

    

24. Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain

    • Rosa María Romero Jiménez
    • Pedro Herranz Pinto
    • Francisco José Rebollo Laserna

    Original Research Article Open access 18 January 2024 Pages: 291 - 302

    

25. Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil

    • Henrique Lima Couto
    • Ludmila Peres Gargano
    • Fernando Zanghelini

    Original Research Article Open access 18 January 2024 Pages: 403 - 416

    

26. Introducing Open Science in Teaching Health Economic Modelling

    • Xavier G. L. V. Pouwels
    • Hendrik Koffijberg

    Practical Application Open access 18 January 2024 Pages: 347 - 357

    

27. From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy

    • Elvio Emanuele Rossini
    • Carlotta Galeone
    • Claudio Jommi

    Original Research Article Open access 16 January 2024 Pages: 251 - 261

    

28. A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma

    • Fei Fei Liu
    • Meaghan Bartlett
    • Samantha Craigie

    Systematic Review Open access 10 January 2024 Pages: 171 - 190

    

29. Health-Related Quality of Life and Economic Burden Among Hospitalized Children with Hand, Foot, and Mouth Disease: A Multiregional Study in China

    • Ting Zhou
    • Hongfei Hu
    • Pei Wang

    Original Research Article Open access 09 January 2024 Pages: 459 - 469

30. Health State Utilities Associated with False-Positive Cancer Screening Results

    • Louis S. Matza
    • Timothy A. Howell
    • Karen C. Chung

    Original Research Article Open access 08 January 2024 Pages: 263 - 276

    

31. Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study

    • Andrew J. Goldberg
    • Ekaterina Bordea
    • the TARVA Study Group

    Original Research Article Open access 08 January 2024 Pages: 235 - 249

    

32. Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies

    • Ankita Kaushik
    • Geoffrey Dusheiko
    • Robert J. Wong

    Original Research Article Open access 03 January 2024 Pages: 333 - 343

    

33. Acknowledgement to Referees

    Acknowledgement to Referees Open access 20 December 2023 Pages: 1 - 3

34. Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark

    • Milanne Maria Johanna Galekop
    • Carin Uyl-de Groot
    • William Ken Redekop

    Original Research Article Open access 19 December 2023 Pages: 313 - 331

    

35. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals

    • Jose Luis Calleja
    • Jaime Espin
    • Adam Igloi-Nagy

    Original Research Article Open access 15 December 2023 Pages: 221 - 233

    

36. The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain

    • Bérengère Macabeo
    • Théophile Rotrou
    • Philippe Laramée

    Original Research Article Open access 14 December 2023 Pages: 5 - 18

    

37. Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden

    • Maria Polyzoi
    • Mattias Ekman
    • Robert Hettle

    Original Research Article Open access 13 December 2023 Pages: 277 - 289

    

38. An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund

    • Laura A. Trigg
    • Maxwell S. Barnish
    • Caroline Farmer

    Original Research Article Open access 12 December 2023 Pages: 303 - 311

    

39. United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument

    • Madeleine T. King
    • D. A. Revicki
    • the MAUCa Consortium

    Original Research Article Open access 07 December 2023 Pages: 49 - 63

    

40. Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15

    • Marty Chaplin
    • Rebecca Bresnahan
    • Pinki Munot

    Correction Open access 05 December 2023 Pages: 1015 - 1015

41. Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis

    • Joost G. E. Verbeek
    • Karen van der Sluis
    • Valesca P. Retèl

    Original Research Article Open access 30 November 2023 Pages: 119 - 131

    

42. Developing a Natural History Model for Duchenne Muscular Dystrophy

    • Jonathan Broomfield
    • M. Hill
    • Project HERCULES, the Cooperative International Neuromuscular Research Group investigators, Duchenne Regulatory Science Consortium members

    Original Research Article Open access 29 November 2023 Pages: 79 - 89

    

43. Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland

    • Andrea Favre-Bulle
    • Min Huang
    • Arjun Bhadhuri

    Original Research Article Open access 24 November 2023 Pages: 91 - 101

    

44. Preferences for Living Arrangements in Dementia: A Discrete Choice Experiment

    • Christian Speckemeier
    • Carina Abels
    • Silke Neusser

    Original Research Article Open access 23 November 2023 Pages: 65 - 78

    

45. Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

    • Hilary M. DuBrock
    • Hayley D. Germack
    • Robert P. Frantz

    Original Research Article Open access 18 November 2023 Pages: 133 - 146

    

46. Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity

    • Laura Gómez Maldonado
    • Ricardo de Mora-Figueroa
    • María Merino

    Original Research Article Open access 15 November 2023 Pages: 103 - 114

47. Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates

    • Jeremy Costin
    • Morgane C. Mouslim
    • Antonio Trujillo

    Original Research Article Open access 03 November 2023 Pages: 115 - 118

48. Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States

    • Ahmed Salem
    • Elizabeth M. La
    • Christopher F. Carpenter

    Original Research Article Open access 02 November 2023 Pages: 975 - 985

    

49. Specialist Palliative Care and Health Care Costs at the End of Life

    • Patricia Kenny
    • Dan Liu
    • Philip Haywood

    Original Research Article Open access 01 November 2023 Pages: 31 - 47

    

50. Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada

    • Reka E. Pataky
    • Stirling Bryan
    • Dean A. Regier

    Original Research Article Open access 11 October 2023 Pages: 997 - 1006